Category: Finance
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners
Private company Aravax to make peanut allergy breakthrough The company’s drug doesn’t cause severe allergic reactions during treatments And here are the recent ASX healthcare [more…]
ASX juniors prove it’s not all doom and gloom at this week’s Jane Morgan Management investor event
A who’s who of ASX listers and investment brokers gathered around the Cottesloe Beach Hotel in Perth earlier this week to listen to presentations by [more…]
The Big Shake-out: Is this the lithium recession we had to have?
The lithium downturn could ‘shake out the fluff’ and put the sector on a road to longer term stability: GL1’s Ron Mitchell Low prices could [more…]
High Voltage: Bone thrown – Macquarie reveals China’s lithium supply down, demand up
• New Macquarie report reveals latest info regarding all-important Chinese lithium supply-demand struggle • Amid, and perhaps partly because of, the Chinese Lunar New Year [more…]
RIU Explorers: Gold is great again but who holds all the aces?
Outlook for gold is strong for 2024 and exploration companies are looking to take advantage Companies such as De Grey Mining and Spartan Resources have [more…]
Navigating the Winds of Change: The Deflationary Shift in January 2024
As the dust settles from the tumultuous pandemic, a new economic narrative is emerging, marked by a significant pullback in inflation. For the first time [more…]
Closing Bell: Local markets in a sulk for the cut that won’t come
ASX200 ends 0.75pc lower after a long slog back from -1.5pc this morning. Industrial Sector only gainer, thanks to a banger from Downer Edi Small [more…]
ASX Large Caps: ASX tumbles as Graincorp sinks 12pc; Downer and AMP shine
ASX falls heavily after US CPI print higher than expected Rates sensitive sectors, gold miners fell CBA, Domain, Fletcher Bulding also dumped The ASX [more…]
Poseidon re-rates nickel potential at Windarra with discovery of new targets
Poseidon identifies two new highly prospective nickel targets at the Windarra project. A recent geological review greatly re-rates the nickel potential, with two new targets [more…]
Long Shortz with Optiscan: Optiscan optimises AI in its fight against GI baddies
Stockhead’s Ashtyn Hiron sits down with Optiscan (ASX:OIL) CEO And Managing Director Dr. Camile Farah to get the short end of the long story on the [more…]
